Carcinogenesis, Vol 18, 801-810, Copyright © 1997 by Oxford University Press
L Shu and PF Hollenberg
The alkylation of DNA, RNA and protein by labeled metabolites of [alpha-
14C]nitrosodimethylamine (NDMA), [alpha-14C]nitrosodipropylamine (NDPA) and
[alpha-14C]nitrosodibutylamine (NDBA) was determined as a measure of the
metabolic activation of these nitrosamine carcinogens in vitro using
microsomes prepared from freshly isolated rat hepatocytes as well as in
intact cells using primary cultured rat hepatocytes. The abilities of these
nitrosodialkylamines to alkylate cellular macromolecules were significantly
affected by pretreatment of rats with inducers of cytochrome P450 and were
related to the specific activities of cytochrome P450 2B1 or 2E1 in rat
hepatocytes. Pretreatment of rats with phenobarbital (PB) substantially
increased the catalytic activity of pentoxyresorufin (PR) O-depentylase, an
activity catalyzed by cytochrome P450 2B1, in rat hepatocytes. The increase
in the PR O- depentylase activity was associated with a significant
increase in the alkylation of DNA or RNA by NDPA, and in alkylation by
NDBA, particularly of proteins. However, induction of cytochrome P450 2B1
resulted in a significant decrease in alkylation of cellular macromolecules
by NDMA in all cases. In contrast, enhancement of the catalytic activity of
the p-nitrophenol (pNP) hydroxylase (P450 2E1) due to pretreatment of rats
with pyridine (PYR) resulted in a significant increase in the alkylation of
cellular DNA by NDMA. The induction of cytochrome P450 2E1 also increased
the alkylation of DNA and RNA by NDPA, but to a lesser extent. Inhibition
studies using the chemical inhibitors orphenadrine (OP) and
diethyldithiocarbamate (DDC), which are specific for cytochromes P450 2B1
and 2E1, respectively, indicated that cytochrome P450 2B1 was not involved
in the metabolic activation of NDMA and that cytochrome P450 2E1 was not
responsible for the bioactivation of NDBA. The results presented here
demonstrate the substrate specificity and important role of cytochromes
P450 2B1 and 2E1 in the bioactivation of nitrosodialkylamines, and suggest
that multiple mechanisms may be involved in carcinogenesis induced by
nitrosodialkylamines.
ARTICLES
Alkylation of cellular macromolecules and target specificity of carcinogenic nitrosodialkylamines: metabolic activation by cytochromes P450 2B1 and 2E1
Department of Pharmacology, The University of Michigan, Ann Arbor 48109- 0634, USA.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
V. Niot-Mansart, A. Muhamedi, and J.-P. Arnould A competitive ELISA detecting 7-methylguanosine adduct induced by N-nitrosodimethylamine exposure Human and Experimental Toxicology, February 1, 2005; 24(2): 89 - 94. [Abstract] [PDF] |
||||
![]() |
Y. Mori, A. Koide, Y. Kobayashi, K. Morimura, M. Kaneko, and S. Fukushima Effect of ethanol treatment on metabolic activation and detoxification of esophagus carcinogenic N-nitrosamines in rat liver Mutagenesis, May 1, 2002; 17(3): 251 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Van Vleet, D. W. Bombick, and R. A. Coulombe Jr. Inhibition of Human Cytochrome P450 2E1 by Nicotine, Cotinine, and Aqueous Cigarette Tar Extract in Vitro Toxicol. Sci., December 1, 2001; 64(2): 185 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Mori, A. Koide, K. Fuwa, and Y. Kobayashi N-Benzylimidazole for preparation of S9 fraction with multi-induction of metabolizing enzymes in short-term genotoxicity assays Mutagenesis, November 1, 2001; 16(6): 479 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Brookman-Amissah, A. G. Mackay, and P. F. Swann Isolation and sequencing of the cDNA of a novel cytochrome P450 from rat oesophagus Carcinogenesis, January 1, 2001; 22(1): 155 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. F. Teiber and P. F. Hollenberg Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine Carcinogenesis, August 1, 2000; 21(8): 1559 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Teyssier and M.-H. Siess Metabolism of Dipropyl Disulfide by Rat Liver Phase I and Phase II Enzymes and by Isolated Perfused Rat Liver Drug Metab. Dispos., June 1, 2000; 28(6): 648 - 654. [Abstract] [Full Text] |
||||




